GlassScriptPhysician profile
Arti Jain
NPI 1972558807
$1,078.18
in general payments reported to CMS, 2019-2025
10 companies · $484 in 2025
The $484 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.96 · 2020: $24.95 · 2021: $96.14 · 2022: $106 · 2023: $178 · 2024: $134 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474 · Long Term Medical Supply Or Device Loan: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.46 |
| Long Term Medical Supply Or Device Loan | $321.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $321.60 | 2025 | Hillrom - Spot Vision Screener |
| Cranial Technologies, INC | $224.22 | 2020-2025 | Doc Band |
| Pfizer INC. | $177.31 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $144.42 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Seqirus USA INC | $75.14 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi Pasteur INC. | $34.08 | 2021-2024 | |
| Cognoa, INC. | $33.30 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $30.83 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $24.82 | 2021 | |
| Kaleo, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arti Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.